Development and validation of a novel prognostic score for HBV-related acute-on-chronic liver failure - Takeaways - MDSpire

Creation and assessment of a new prognostic scoring system for HBV-associated acute-on-chronic liver failure

  • By

  • Qian Song

  • Lin Lv

  • Chuanfei Li

  • Zhechuan Mei

  • Shengtao Liao

  • July 17, 2026

Share

  • 1

    A new prognostic scoring system for HBV-associated acute-on-chronic liver failure was developed and validated using 1170 patient cases.

  • 2

    The new AHF-MELD and AHN-MELD scores demonstrated stronger predictive capacity compared to existing models like MELD and CLIF-C.

  • 3

    The study utilized cox regression analysis to identify key predictive factors for 28-day and 90-day mortality in HBV-ACLF patients.

  • 4

    The new scores showed no significant difference between observed and predicted mortality probabilities at 28 and 90 days.

  • 5

    High-risk groups identified by the new scores had significantly lower survival rates compared to low-risk groups.

Original Source(s)

Development and validation of a novel prognostic score for HBV-related acute-on-chronic liver failure

  • by Qian Song, Lin Lv, Chuanfei Li, Zhechuan Mei, Shengtao Liao

  • July 17, 2026

Related Content

Determinants of metabolic dysfunction associated steatotic liver disease and liver fibrosis in patients with type 2 diabetes mellitus: a cross-sectional study

Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies

Comparison of learning curve difference of laparoscopist according to controller type of flexible scope during laparoscopic liver resection